📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Goldman Sachs bearish on Fevertree Drinks stock, cites earnings potential

EditorEmilio Ghigini
Published 05/28/2024, 04:24 AM
© Reuters.
FEVR
-

On Tuesday, Goldman Sachs revised its stance on Fevertree Drinks Plc (FEVR:LN) (OTC: FQVTF) stock, downgrading the rating from Neutral to Sell.

The investment firm also adjusted its price target to 1,050p from the previous 1,075p. The downgrade comes amid concerns about the company's earnings potential and valuation.

The analyst from Goldman Sachs noted that while Fevertree's projected earnings per share (EPS) growth of 18% from fiscal year 2025 to 2027 is appealing, it is primarily due to easing costs of goods sold (COGS) rather than a significant acceleration in underlying sales. This shift in growth drivers may not align with investor expectations for Fevertree, which is commonly viewed as a growth stock.

Investors may find the forecasted medium-term organic sales growth rate of 7.4% less compelling when compared to the company's current valuation, which stands at 31 times the calendar year 2025 estimated price-to-earnings (P/E) ratio. The analyst expressed a belief that the market's current valuation of Fevertree is demanding, given the modest sales growth outlook.

Goldman Sachs also anticipates potential downside risks to Fevertree's EPS, with their estimates for fiscal years 2024, 2025, and 2026 being 3%, 4%, and 7% lower, respectively, than the consensus. These revised estimates underpin the firm's decision to downgrade the stock.

The price target reduction reflects the analyst's revised earnings expectations and the perceived challenges in Fevertree's growth trajectory. The new target of 1,050p represents a slight decrease from the previous target but underscores the cautious outlook from Goldman Sachs on the stock's future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.